Status:
COMPLETED
Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Pregnancy
HIV Infections
Eligibility:
FEMALE
14-21 years
Phase:
PHASE4
Brief Summary
This study will evaluate the effectiveness of CenteringPregnancy Plus, a group prenatal care treatment program with an HIV/sexually transmitted disease prevention component, in reducing health risk be...
Detailed Description
It is estimated that each year 1 out of 4 teenagers becomes infected with a sexually transmitted disease (STD), which may include chlamydia, herpes, human papillomavirus, or HIV. Teenagers are especia...
Eligibility Criteria
Inclusion
- Pregnant
- Able to attend group treatment sessions conducted in English or Spanish
Exclusion
- Positive HIV infection
- Severe medical problem requiring individualized assessment and tracking as high-risk pregnancy
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
1233 Patients enrolled
Trial Details
Trial ID
NCT00628771
Start Date
June 1 2008
End Date
September 1 2012
Last Update
April 3 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale University School of PUblic Health
New Haven, Connecticut, United States, 06510
2
Centering Healthcare Institute
Boston, Massachusetts, United States, 02111
3
Clinical Directors Network
New York, New York, United States, 10018